Maddison Rose
Impact in
- Oncology top 10%
- PARP inhibition in cancer therapy
-
- Cancer, Hypoxia, and Metabolism
Papers in
-
- DNA Repair Mechanisms 5
- Nuclear Structure and Function 3
- RNA Research and Splicing 2
- Epigenetics and DNA Methylation 1
- Oncology 3
- PARP inhibition in cancer therapy 2
- Cancer-related Molecular Pathways 2
- Co-authors
- Kenneth J. O’Byrne (7 shared papers)Emma Bolderson (7 shared papers)Derek J. Richard (7 shared papers)Joshua T. Burgess (6 shared papers)Amila Suraweera (3 shared papers)Didier Boucher (2 shared papers)Mark N. Adams (3 shared papers)Connor O’Leary (1 shared paper)
- Journals
- Frontiers in Cell and Developmental Biology (3 papers)Scientific Reports (1 paper)Frontiers in Oncology (1 paper)Nucleic Acids Research (1 paper)Cancer and Metastasis Reviews (1 paper)
- Partner nations
- Australia
In The Last Decade
Maddison Rose
7 papers receiving 593 citations
Maddison Rose's Hit Papers
Peers
Comparison fields: 5 of 78
- Oncology 358
- Cancer Research 106
- Molecular Biology 356
- Reproductive Medicine 41
- Immunology 52
Countries citing papers authored by Maddison Rose
This map shows the geographic impact of Maddison Rose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maddison Rose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maddison Rose more than expected).
Fields of papers citing papers by Maddison Rose
This network shows the impact of papers produced by Maddison Rose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maddison Rose. The network helps show where Maddison Rose may publish in the future.
Co-authors
The 14 scholars most cited alongside Maddison Rose, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance Hit paper breakdown → | 2020 | 455 |
| 2 | 2021 | 49 | |
| 3 | 2020 | 41 | |
| 4 | 2023 | 20 | |
| 5 | 2021 | 16 | |
| 6 | 2022 | 8 | |
| 7 | 2021 | 8 |
About Maddison Rose
Maddison Rose is a scholar working on Molecular Biology, Oncology, Cancer Research, Cell Biology and Genetics, having authored 7 papers that have together received 597 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (5 papers), Nuclear Structure and Function (3 papers), RNA Research and Splicing (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), PARP inhibition in cancer therapy (2 papers), Cancer-related Molecular Pathways (2 papers), Epigenetics and DNA Methylation (1 paper) and BRCA gene mutations in cancer (1 paper). The work is most often cited by research in Oncology (358 citations), Cancer Research (106 citations), Molecular Biology (356 citations), Reproductive Medicine (41 citations) and Immunology (52 citations). Maddison Rose has collaborated with scholars based in Australia. Frequent co-authors include Kenneth J. O’Byrne, Emma Bolderson, Derek J. Richard, Joshua T. Burgess, Amila Suraweera, Didier Boucher, Mark N. Adams, Connor O’Leary, Mark Fisher and Chee Man Cheong. Their work appears in journals such as Frontiers in Cell and Developmental Biology, Scientific Reports, Frontiers in Oncology, Nucleic Acids Research and Cancer and Metastasis Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.